Artwork

Contenido proporcionado por BackTable Inc.. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BackTable Inc. o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

Introducing Backtable Tumor Board

2:09
 
Compartir
 

Manage episode 461450881 series 2658136
Contenido proporcionado por BackTable Inc.. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BackTable Inc. o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

Welcome to the first episode of BackTable Tumor Board, and our first recording session at our new in-person studio! Guest host Dr. Tyler Sandow (interventional radiologist) leads a multidisciplinary discussion about patient care coordination in hepatocellular carcinoma (HCC) diagnosis and treatment, with insights from his colleagues at Ochsner Health– Dr. Steven Young (hepatologist), Dr. Jonathan Mizrahi (medical oncologist), and Deondra Bonds-Adams (patient navigator).

---

This podcast is supported by an educational grant from:

AstraZeneca

https://www.astrazeneca.com/our-therapy-areas/oncology.html

With additional support from:

Boston Scientific

https://www.bostonscientific.com/en-US/medical-specialties/interventional-radiology/interventional-oncology.html

---

SYNPOSIS

The team speaks on the value of having multiple specialties weigh in on treatment conversations that are tailored to each patient’s medical history and risk factors, such as underlying cirrhosis and portal hypertension. Deondra highlights the importance of assessing the patient’s understanding of their disease and the role of physician extenders and schedulers in patient education. Dr. Young discusses the value of outreach clinics and streamlining the transplant evaluation process. Finally, Dr. Mizrahi gives advice on building referral networks and establishing early contact with transplant centers.

---

TIMESTAMPS

00:00 - Introduction

00:46 - Multidisciplinary Tumor Board

06:00 - Patient Experience in Treatment Pathways

10:10 - Barriers to Treatment

16:03 - Benefits of IR Clinic

19:33 - HCC Screening and Risk Factors

24:08 - Building Referral Networks

30:34 - Strategies for Effective Scheduling

35:43 - The Future of HCC Treatment

  continue reading

523 episodios

Artwork
iconCompartir
 
Manage episode 461450881 series 2658136
Contenido proporcionado por BackTable Inc.. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BackTable Inc. o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

Welcome to the first episode of BackTable Tumor Board, and our first recording session at our new in-person studio! Guest host Dr. Tyler Sandow (interventional radiologist) leads a multidisciplinary discussion about patient care coordination in hepatocellular carcinoma (HCC) diagnosis and treatment, with insights from his colleagues at Ochsner Health– Dr. Steven Young (hepatologist), Dr. Jonathan Mizrahi (medical oncologist), and Deondra Bonds-Adams (patient navigator).

---

This podcast is supported by an educational grant from:

AstraZeneca

https://www.astrazeneca.com/our-therapy-areas/oncology.html

With additional support from:

Boston Scientific

https://www.bostonscientific.com/en-US/medical-specialties/interventional-radiology/interventional-oncology.html

---

SYNPOSIS

The team speaks on the value of having multiple specialties weigh in on treatment conversations that are tailored to each patient’s medical history and risk factors, such as underlying cirrhosis and portal hypertension. Deondra highlights the importance of assessing the patient’s understanding of their disease and the role of physician extenders and schedulers in patient education. Dr. Young discusses the value of outreach clinics and streamlining the transplant evaluation process. Finally, Dr. Mizrahi gives advice on building referral networks and establishing early contact with transplant centers.

---

TIMESTAMPS

00:00 - Introduction

00:46 - Multidisciplinary Tumor Board

06:00 - Patient Experience in Treatment Pathways

10:10 - Barriers to Treatment

16:03 - Benefits of IR Clinic

19:33 - HCC Screening and Risk Factors

24:08 - Building Referral Networks

30:34 - Strategies for Effective Scheduling

35:43 - The Future of HCC Treatment

  continue reading

523 episodios

Todos los episodios

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida

Escucha este programa mientras exploras
Reproducir